Hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 , HAp) and dicalcium phosphate anhydrous (Ca(H 2 PO 4 ) 2 , DCPA) were coated onto titanium substrates using the thermal substrate method in an aqueous solution containing calcium and phosphate ions at 150 • C with pH values in the range 4-8. Specimens with the HAp and DCPA layer were immersed in a simulated body fluid (SBF) to examine the dissolution and induced HAp growth behaviour of the coated layers in the SBF. No precipitation occurred on the coated DCPA layer after 7 days immersion in the SBF, and also the DCPA did not dissolve in the SBF. On the other hand, a new precipitate, which was identified as HAp, nucleated after 1 day and grew in a spherical manner on soaking the HAp substrate specimens in the SBF. The influence of small quantities of DCPA in the HAp layer on the coating's bioactive property in the SBF was negligible as the DCPA was not on the surface of the coated layer.
Introduction
Calcium phosphates, and specifically hydroxyapatite (Ca 10 (PO 4 ) 6 (OH) 2 , HAp), are of interest in bone-interfacing implant applications because of their demonstrated osteoconductive properties. 1) Hydroxyapatite is considered to be a bioactive material, and is used in the fabrication of medical and dental implants, usually in the form of a coating on a metallic substrate to compensate for its poor intrinsic mechanical properties. Such designs are intended to take advantage of the bioactivity of HAp in combination with the mechanical strength of the metallic substrate. Many methods of forming HAp and other calcium phosphate coatings on metallic substrates have been reported. We have proposed a new hydro-coating method for calcium phosphate, the thermal substrate method, which overcomes several weak points of traditional hydro-processes. 2) Experimental results of the coatings of HAp on substrates have already been reported. 2) In the papers on hydro-process, [3] [4] [5] [6] [7] [8] [9] [10] several factors affecting the HAp coating have been extensively examined, such as the solute concentration, the pH, ion concentration, and additives. We have already confirmed experimentally that the ion source, the molar ratio Ca/P, the temperature, and the surface roughness of the substrate have an effect on the type and the amount of precipitate produced, and on the surface morphology. 2, 11) These works show that single-phase layers of HAp and dicalcium phosphate anhydrous (Ca(H 2 PO 4 ) 2 , DCPA), and layers that contain both HAp and DCPA can be obtained. However, we can not judge whether two-phase specimens with HAp and DCPA are effective as implantable materials, because the osteoinduction of calcium phosphatebased biomaterials, such as HAp and β-tricalcium phosphate (β-Ca 3 (PO 4 ) 2 , β-TCP), is controversial. Moreover, the in vivo passive dissolution of dicalcium phosphate dihydrate (Ca(H 2 PO 4 ) 2 2H 2 O, DCPD) has been reported, 13) but as far as the authors are concerned, there are many uncertainties in the in vivo osteoinductivity of DCPA and DCPD. Therefore, the single phase layers of HAp and DCPA and composite layer consists of both phases coated onto Ti substrates using the thermal substrate method were immersed in a simulated body fluid (SBF), and the in vitro dissolution and HAp-inductivity behaviour of the coated layers in the SBF were examined. Figure 1 shows the experimental apparatus used to obtain the calcium phosphate coatings. The aqueous solution consisted of 7 mM CaCl 2 and 3 mM Ca(H 2 PO 4 ) 2 , and in some cases H 3 PO 4 was added to the solution. The unit "M" denotes mol dm −3 . The pH of the solution was adjusted from 4 to 8 by the addition of aqueous NaOH. The Ti specimens (48 × 6 × t0.03 mm 3 ) were polished with SiC emery paper (#220 grid) before the coating process. The specimens were attached to copper electrodes using stainless steel bolts, and were immersed in 0.3 dm 3 of the aqueous solution and shaken in order to release any air bubbles that may have adhered to their surfaces. An alternating current (up to 25 A) was passed through the substrates via the copper electrodes, which resulted in the heating of the substrates. The temperature of the specimen was measured using a calibrated thermocouple, which was in contact with the surface of the specimens. The temperature was maintained at 150
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• C for 20 min. using the current amplitude, and the coating process was terminated by switching off the power. The properties of the coated samples were studied using X-ray diffraction (XRD), energy dispersive X-ray analysis (EDX), Fourier-transform infrared spectroscopy (FT-IR), and scanning electron microscopy (SEM).
In vitro evaluation
The bioactive properties of the coatings, produced with the above method, in an SBF were evaluated. The SBF solution used was equivalent to that used by Kokubo and co-workers, 14) and consisting of 142 mM Na . The SBF was buffered at pH = 7.4 and 36.5
• C using 50 mM tris(hydroxymethyl) amminomethane ((CH 2 OH) 3 CNH 3 ) and HCl. Each coated specimen (6 × 10 × t0.03 mm 3 ) was soaked in 25 cm 3 of the SBF maintained at 36.5
• C for various time periods (maximum duration 7 d). The samples were removed from the fluid, washed with distilled water, dried in air, and then assessed using XRD, FT-IR, and SEM.
Results and Discussion
Calcium phosphate coatings
Figures 2 and 3 show SEM photographs and XRD patterns of specimens coated at 150
• C for 20 min. in the solution explained in Section 2.1, where pH of the solution is (a) 5.0, and (b) 6.0. The precipitate at pH = 5.0 appeared to pile up like bricks, and was identified as DCPA from XRD analysis. In the solution at pH = 6.0, on the other hand, thin platelike crystals were formed, and it was clear that the precipitate was composed of HAp. The pH dependency of the solubility of the calcium phosphate compounds explains why the precipitate changed with increasing pH of the solution, i.e. the solubility curves of DCPA and HAp cross at approximately pH 5 in the solubility curves of various compounds on calcium phosphate. 11, 12) This means the change of the pH in the solution interchanges the solubilities, and DCPA precipitates more easily than HAp when the pH is less than 5.
In the cases of the solution consisting of (i) H 3 PO 4 and CaCl 2 , (ii) HAp and HCl, or (iii) Ca(H 2 PO 4 ) 2 and Ca(OH) 2 , instead of Ca(H 2 PO 4 ) 2 and CaCl 2 , respectively, there was no significant difference in the type and morphology of the precipitate.
11) When the concentration of NaOH added to the solution to adjust the pH was greater than 0.1 M, then Na 2 HPO 4 was precipitated in the solution instead of HAp. This resulted in a decrease in the phosphate ion content of the solution, and prevented the formation of calcium phosphates on the substrate. Therefore, in our experiment NaOH addition controlled to below 0.1 M. Figure 4 shows the change of the surface morphology with soaking time on the coated calcium phosphate specimens shown in Figs. 2 and 3 , which were soaked in the SBF for 1 d to 7 d. No new precipitate could be seen on the DCPA coated sample, even after the soaking for 7 d (Fig. 4(a) ). Moreover, no DCPA had dissolved into the SBF either, even though the SBF used at pH = 7.4 was unsaturated with respect to the DCPA. It is thought that the DCPA has precipitation and dissolution behaviour similar to that of HAp, i.e. it is difficult for HAp to precipitate from a supersaturated solution, and also to dissolve into an unsaturated solution. We have confirmed that the DCPA coatings obtained by the thermal substrate method do not have any osteoinduction (HAp-induction) in the SBF.
In vitro evaluation
In the case of soaking HAp coatings, a new precipitate nucleated and gradually grew in a spherical fashion as shown in Fig. 4(b) . The new precipitate was identified as HAp by XRD analysis (Fig. 5) , and the amount of the precipitate on the substrate was found to increase from ICP-AES analysis. The new HAp precipitate from the SBF was denoted as "Ap" to distinguish it from the coated HAp. From the change of the XRD patterns with soaking time, the small quantity of DCPA, which was initially included in the HAp coating (Fig. 2(b) ), disappeared after soaking for 7 d, even though DCPA was observed not to dissolve into the SBF, as mentioned above. It is considered that because of the large quantity of Ap that had precipitated on the HAp, the XRD could not detect the presence of the DCPA. Figure 6 shows FT-IR spectra of HAp coated specimens, (a) before, and (b) after soaking in the SBF for 7 d, respectively. 15) There were no significant differences in the FT-IR spectra between two samples. It was clear that the precipitate was HAp, and that it included a small quantity of CO 2− 3 . Therefore, the Ap (and HAp) crystal was identified as carbonate-containing HAp 16, 17) in which the CO formed in a similar manner to the mechanism proposed by Kim et al. 16) In the in vitro experiment, the coated specimen was soaked in the SBF for up to 7 d continuously, without changing the SBF. The decrease in Ca 2+ content in the SBF after soaking for 7 d was ca. 1% with respect to the initial content (2.5 mM), and this decrease did not influence the precipitation of Ap from the SBF.
Influence of the coexistence of DCPA in the HAp
coatings on the Ap precipitation As described above, DCPA did not dissolve into the SBF, and Ap was not precipitated on DCPA coatings that were soaked in the SBF. In the present work, the layers that contained both HAp and DCPA were obtained in some cases. There is a concern that precipitation of Ap on the coated HAp layer in the SBF was prohibited because the HAp coating contained a small quantity of DCPA, in addition to the main component, HAp, as DCPA does not have any Ap-inductivity. Therefore, experiments were conducted by using the following two specimens to compare the Ap-inductivity: (a) a specimen in which almost all the coexisting DCPA was transformed to HAp by immersing the coating in an aqueous 1N NaOH solution at a temperature of 80
• C for 24 h, 18, 19) which was fabricated from a solution containing 7 mM CaCl 2 and 3 mM Ca(H 2 PO 4 ) 2 at pH = 6.0 at a temperature of 150
• C for 20 min. coated layer, not on the surface of the coated layer, because no typical DCPA crystals were found on the surface of the ascoated samples, even though DCPA was detected by XRD. This is the reason why there was no difference in the behaviour of Ap precipitation from the SBF. Cross-sectional observations of the sample also did not reveal any DCPA crystals both before and after soaking in the SBF because the coated layer was very thin (ca. 1 µm). Therefore, the influence on the bioactive properties (Ap-inductivity) from the presence of a small quantity of DCPA coexisting with the HAp was negligible, as the DCPA was not on the surface of the coated layer.
Conclusion
HAp and DCPA layers coated on Ti substrates by means of the thermal substrate method were immersed in the SBF, and the dissolution and HAp-induction behaviour of the coated layers was examined.
(1) In the case of soaking the specimens with the HAp coating in the SBF, Ap nucleated and grew spherically. This implies that the HAp coating has a HAp-induction (osteoinduction) property in the SBF. However, no new precipitate was found in the case of DCPA coatings and no DCPA dissolved into the SBF, even after soaking in the SBF for 7 d.
(2) As for the osteoinduction, the influence of a small quantity of DCPA in the HAp layer coated by this method was negligible. The reason of this behaviour is a small quantity of DCPA does not exist of on the surface of the HAp coating, but on the interface between the Ti substrate and the HAp coating.
with a little DCPA in the coating (Fig. 4(b) ), there was no significant difference in the Ap precipitation behaviour from the SBF in the SEM photographs. The XRD patterns and FT-IR spectra also showed no differences. In reference to Fig. 2(b) and Figs. 8(a) and (b) , it is considered that a small quantity of DCPA was on the interface between the substrate and the
